B

Bicara Therapeutics Inc
NASDAQ:BCAX

Watchlist Manager
Bicara Therapeutics Inc
NASDAQ:BCAX
Watchlist
Price: 9.67 USD 4.43%
Market Cap: 527.4m USD

Wall Street
Price Targets

BCAX Price Targets Summary
Bicara Therapeutics Inc

Wall Street analysts forecast BCAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCAX is 33.25 USD with a low forecast of 8.08 USD and a high forecast of 50.4 USD.

Lowest
Price Target
8.08 USD
16% Downside
Average
Price Target
33.25 USD
244% Upside
Highest
Price Target
50.4 USD
421% Upside
Bicara Therapeutics Inc Competitors:
Price Targets
SLNO
Soleno Therapeutics Inc
37% Upside
6955
Shandong Boan Biotechnology Co Ltd
24% Downside
EDIT
Editas Medicine Inc
11% Upside
ANAB
AnaptysBio Inc
69% Upside
NRIX
Nurix Therapeutics Inc
142% Upside
RNA
Avidity Biosciences Inc
114% Upside
AMGN
Amgen Inc
7% Upside
603087
Gan & Lee Pharmaceuticals
12% Upside

Revenue
Forecast

Revenue Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCAX's stock price target?
Price Target
33.25 USD

According to Wall Street analysts, the average 1-year price target for BCAX is 33.25 USD with a low forecast of 8.08 USD and a high forecast of 50.4 USD.

Back to Top